Islet Transplantation in Type 1 Diabetics Using an Immunosuppressive Protocol Based on the Anti-LFA-1 Antibody Efalizumab
Open Access
- 23 July 2010
- journal article
- Published by Elsevier BV in American Journal of Transplantation
- Vol. 10 (8), 1870-1880
- https://doi.org/10.1111/j.1600-6143.2010.03073.x
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Progressive Multifocal Leukoencephalopathy in Patients on Immunomodulatory TherapiesAnnual Review of Medicine, 2010
- Successful Clinical Islet Isolation Using a GMP-Manufactured Collagenase and Neutral ProteaseTransplantation, 2009
- Human FOXP3+ Regulatory T Cells in TransplantationAmerican Journal of Transplantation, 2009
- Stem Cells to Pancreatic β-Cells: New Sources for Diabetes Cell TherapyEndocrine Reviews, 2009
- Efalizumab discontinuation: A practical strategyJournal of Dermatological Treatment, 2009
- Progressive Multifocal Leukoencephalopathy and Use of Mycophenolate Mofetil After Kidney TransplantationTransplantation, 2008
- Advances in immunosuppression for pancreas transplantationCurrent Opinion in Organ Transplantation, 2008
- Stem Cell Therapy to Treat Diabetes MellitusThe Review of Diabetic Studies, 2008
- The Islet Transplant Experiment: Time for a ReassessmentAmerican Journal of Transplantation, 2007
- Simple Measures to Monitor b -Cell Mass and Assess Islet Graft DysfunctionAmerican Journal of Transplantation, 2007